PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12410571-0	2002	Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression.	Daunorubicin	63-75	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	14-21	
12410571-9	2002	The median LD(50) of daunorubicin (concentration lethal to 50% of the leukemic blasts) differed significantly between bcr-abl-positive and -negative patients (P = 0.018).	Daunorubicin	21-33	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	118-125	
12410571-10	2002	This in vitro study suggests that bcr-abl-positive ALL is relatively resistant to daunorubicin, but this resistance is not mediated through mdr1 gene expression.	Daunorubicin	82-94	ABL proto-oncogene 1, non-receptor tyrosine kinase	Homo sapiens	34-41